(Q54214540)
Statements
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule. (English)
Schilder RJ
LaCreta FP
Perez RP
Johnson SW
Brennan JM
Rogatko A
Nash S
McAleer C
Hamilton TC
Roby D
1 February 1994
54
3
709-717